Piezo1 Activation Improves NSCLC Liver Metastasis Immunotherapy by Overriding Matrix Stiffness-Mediated Bimodal PD-L1/CXCL10 Regulation

Piezo1激活通过克服基质刚度介导的PD-L1/CXCL10双峰调控,增强非小细胞肺癌肝转移免疫治疗效果。

阅读:1

Abstract

Immunotherapy efficacy in NSCLC is significantly reduced upon liver metastasis due to profound alterations in the tumor microenvironment, characterized by the absence of cyclic mechanical stretch and increased extracellular matrix (ECM) stiffness. However, the mechanisms underlying the synergistic regulation of these two mechanical cues on the immunotherapy response in NSCLC cells remain poorly understood. In this study, it is demonstrated that both mechanical and biochemical activation of the mechanosensitive ion channel Piezo 1 induces nuclear translocation of YAP, thereby promoting an immunotherapy-responsive tumor immune microenvironment (TIME) through enhanced expression of PD-L1 and secretion of chemokine C-X-C ligand 10 (CXCL10, chemokine recruiting CD8(+) T cells) in NSCLC cells. The mathematical modeling further reveals that cyclic stretch modulates the PD-L1/CXCL10 response to ECM stiffness, shifting from a bimodal to a unimodal distribution. In a murine model of liver metastasis, the combination of Piezo 1 agonist with anti-PD-1 therapy significantly improves the immunotherapy response, as evidenced by elevated PD-L1 levels and increased CD8(+) T cell infiltration. These findings underscore the critical role of Piezo 1 in enhancing the immunotherapeutic response in NSCLC liver metastasis and highlight its potential as a therapeutic target.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。